Languages endefrczpl

In-vivo challenge trials

Enteric® suppresses a clinical infection of necrotic enteritis when the birds are challenged with coccidiosis & Clostridium perfringens infection.

NECROTIC ENTERITIS CHALLENGE TRIAL

NECROTIC ENTERITIS CHALLENGE TRIAL

PERFORMANCE trials

In regular broiler trials Enteric® suppresses subclinical necrotic enteritis and improvements in animal performance and litter quality are observed.

Enteric® Recommendation

Application of Enteric® during whole feed cycle, Enteric® dry at 500 g /t feed or Enteric® HC dry at 50 g/t feed.

Enteric® KEY BENEFITS

Enteric® mode of action

No. 1 in poultry production

A disrupted gut will quickly lead to sub clinical necrotic enteritis which is a widespread problem in the poultry industry. It is known as a serious profit killer. The industry has been evaluating several routes to lower the incidence of sub clinical necrotic enteritis.

Enteric® is a unique active microbial that was selected for its targetted activity against Clostridium perfringens*. It was isolated from the gut of a healthy chicken. Several trials have demonstrated the activity of Enteric® in broilers.

*Certain statements may not be applicable in all geographical regions. Product labeling and associated claims may differ based upon government requirements.